 NEW YORK, Oct. 18, 2021 PRNewswire -- BrainStorm Cell Therapeutics Inc. NASDAQ: BCLI, a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, Therapeutic Benefits of MSC-NTF NurOwn Exosomes in Acute Lung Injury Models at the NYSCF 2021 VIRTUAL Meeting, being held on October 19-20, 2021. The poster will be presented tomorrow, October 19, at 3:45 5:00pm Eastern Time. 